Quantum-Si Highlights Technology Advancements at the VIB Next-Generation Protein Analysis and Detection Conference
5 min read
Quantum-Si demonstrates a route to permit >70% coverage of the human proteome and the identification of up to 90% of proteins, which include article-translational modifications
Organization carries on to progress the core engineering as it progresses in direction of commercialization of its Platinum™ Protein Sequencing System later on this yr
GUILFORD, Conn., June 01, 2022–(Organization WIRE)–Jun. 1, 2022 — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Business”), a life sciences enterprise commercializing one molecule protein sequencing, declared that Brian Reed, Ph.D., Head of Research at Quantum-Si, introduced an update on the Company’s technologies improvements at the Up coming-Era Protein Assessment and Detection Convention, a VIB Resources & Technologies convention, in Ghent, Belgium. The presentation is obtainable on the Investors area of the Quantum-Si web site beneath Activities & Shows.
Dr. Reed discussed Quantum-Si’s analysis and improvement development, together with the expansion of the technological innovation to interrogate more of the human proteome and its estimated 1,000,000+ proteoforms. This is essential for researchers to attain insights into how protein changes influence ailment states. Reed also provided an overview of Quantum-Si’s protein sequencing technological know-how platform, including Platinum™, which uses a proprietary and novel strategy identified as Time Domain Sequencing™ to exactly decode the get of amino acids in a protein and interrogate alterations for the identification of new drug targets and diagnostic biomarkers. The capability to straight sequence proteins from a assortment of sample styles will produce new purposes throughout disciplines these as oncology, neurology and cardiology.
“We have invested greatly in protein engineering and directed evolution methods to speed up the growth of amino acid recognizers and maximize the proportion of the proteome that we can detect,” claimed Reed. “To date, we have created sizeable progress toward industrial start, possessing now shown successful on-chip recognition of 15 out of 20 amino acids. These 15 amino acids stand for a path to more than 70% protection of the human proteome, identification of up to 90% of proteins, as well as a bigger comprehension of protein sequence variation and post-translational modifications. Upcoming developments of the platform will improve the accessibility of proteomics experiments and allow new discoveries in biological and medical analysis.”
To learn a lot more about Quantum-Si’s technologies, obtain the Company’s most up-to-date whitepaper, titled “Digitizing Protein Sequencing: Detecting Individual Amino Acids by Actual-Time Photon Emission,” right here.
About Quantum-Si Included
Quantum-Si is targeted on revolutionizing the increasing area of proteomics. The Company’s suite of systems is driven by a very first-of-its-form semiconductor chip built to enable solitary molecule subsequent-generation protein sequencing and digitize proteomic exploration in order to progress drug discovery and diagnostics further than what has been attainable with DNA sequencing. Understand additional at www.quantum-si.com.
Ahead On the lookout Statements
This push release incorporates “forward-searching statements” in just the indicating of the “secure harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The actual benefits of the Firm may well vary from its anticipations, estimates, and projections and, for that reason, you ought to not rely on these ahead-searching statements as predictions of potential activities. Terms these types of as “hope,” “estimate,” “challenge,” “price range,” “forecast,” “anticipate,” “intend,” “system,” “may,” “will,” “could,” “should,” “thinks,” “predicts,” “potential,” “keep on,” and very similar expressions (or the adverse variations of these words and phrases or expressions) are supposed to discover such forward-hunting statements. These forward-hunting statements involve, with out limitation, the Firm’s expectations with respect to upcoming overall performance and advancement and commercialization of items and providers. These ahead-looking statements involve sizeable risks and uncertainties that could induce the true effects to vary materially from individuals mentioned in the forward-searching statements. Most of these components are outdoors the Firm’s command and are complicated to forecast. Aspects that may perhaps cause such variances involve, but are not limited to: the influence of COVID-19 on the Firm’s company the incapacity to keep the listing of the Firm’s Course A frequent inventory on The Nasdaq Inventory Marketplace the potential to figure out the anticipated added benefits of the not long ago accomplished business mixture, which may well be afflicted by, amid other matters, levels of competition and the means of the Organization to develop and deal with growth profitably and keep its vital employees our ongoing management transition modifications in applicable legal guidelines or restrictions the capability of the Enterprise to elevate financing in the long run the accomplishment, cost and timing of the Company’s solution enhancement and commercialization functions the prospective characteristics and rewards of the Firm’s products and solutions and providers the Firm’s capability to attain and keep regulatory acceptance for its products, and any linked constraints and limits of any approved item the Company’s capacity to establish, in-license or receive added technological know-how the Company’s skill to manage its present lease, license, manufacture and source agreements the Firm’s ability to compete with other providers at this time internet marketing or engaged in the improvement or commercialization of products and expert services that the Enterprise is developing the sizing and progress prospective of the markets for the Firm’s potential items and companies, and its skill to provide people marketplaces, possibly by yourself or in partnership with many others the pricing of the Firm’s solutions and providers pursuing anticipated industrial launch the Firm’s estimates regarding foreseeable future fees, long run income, funds necessities and requires for further financing the Company’s money overall performance and other threats and uncertainties explained beneath “Threat Elements” in the Company’s Yearly Report for the fiscal yr ended December 31, 2021, and in the Company’s other filings with the SEC. The Organization cautions that the foregoing checklist of things is not distinctive. The Enterprise cautions audience not to put undue reliance on any forward-wanting statements, which discuss only as of the day produced. The Company does not undertake or settle for any obligation or enterprise to release publicly any updates or revisions to any forward-seeking statements to reflect any adjust in its expectations or any improve in functions, ailments, or situation on which any these types of assertion is based.
Look at supply version on businesswire.com: https://www.businesswire.com/information/home/20220601005830/en/
Contacts
Investors
Juan Avendano
Mike Cavanaugh
[email protected]
Media
Karen Chase
[email protected]